Cargando…

Variability of Blood Eosinophil Count at Stable-State in Predicting Exacerbation Risk of Chronic Obstructive Pulmonary Disease

BACKGROUND: Chronic obstructive pulmonary disease (COPD) phenotyping using stable-state blood eosinophil level was shown to have prognostic implication in terms of exacerbation risk. However, using a single cut-off of blood eosinophil level to predict clinical outcome has been challenged. There have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwok, Wang Chun, Chau, Chi Hung, Tam, Terence Chi Chun, Lam, Fai Man, Ho, James Chung Man
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10274840/ https://www.ncbi.nlm.nih.gov/pubmed/37332837 http://dx.doi.org/10.2147/COPD.S401357

Ejemplares similares

Blood eosinophil percentage as a predictor of response to inhaled corticosteroid in bronchiectasis
por: Kwok, Wang Chun, et al.
Publicado: (2023)

Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemic
por: Chan, King Pui Florence, et al.
Publicado: (2020)

Variability of blood eosinophil count and prognosis of COPD exacerbations
por: Martínez-Gestoso, Sandra, et al.
Publicado: (2021)

Blood Eosinophil Count and Hospital Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Hegewald, Matthew J, et al.
Publicado: (2020)

Eosinophil values in exacerbation and stable chronic obstructive pulmonary disease and its relationship to maintenance therapy in stable chronic obstructive pulmonary disease patients
por: Fachri, Muhammad, et al.
Publicado: (2023)

Territory-Wide Study on Hospital Admissions for Asthma Exacerbations in the COVID-19 Pandemic
por: Chan, King-Pui Florence, et al.
Publicado: (2021)

Pulmonary embolism developing after therapeutic drainage of malignant pleural effusions
por: Kwok, Wang Chun, et al.
Publicado: (2018)

Risk factors for Pseudomonas aeruginosa colonization in non-cystic fibrosis bronchiectasis and clinical implications
por: Kwok, Wang Chun, et al.
Publicado: (2021)

Serum protein level as a predictor of therapeutic response and adverse effects associated with afatinib use
por: Kwok, Wang Chun, et al.
Publicado: (2022)

Survival benefits from afatinib compared with gefitinib and erlotinib among patients with common EGFR mutation in first‐line setting
por: Kwok, Wang Chun, et al.
Publicado: (2022)

Blood Eosinophil and Risk of Exacerbation in Chronic Obstructive Pulmonary Disease Patients: A Retrospective Cohort Analysis
por: Chan, Ming Chiu, et al.
Publicado: (2020)

Blood Eosinophil Count as a Predictive Biomarker of Chronic Obstructive Pulmonary Disease Exacerbation in a Real-World Setting
por: Komura, Moegi, et al.
Publicado: (2023)

The association between eosinophilic exacerbation and eosinophilic levels in stable COPD
por: Kang, Hye Seon, et al.
Publicado: (2021)

Control of brain metastases with alectinib in anaplastic lymphoma kinase‐rearranged lung cancer
por: Kwok, Wang Chun, et al.
Publicado: (2017)

Differences in the lipid metabolism profile and clinical characteristics between eosinophilic and non-eosinophilic acute exacerbation of chronic obstructive pulmonary disease
por: Wang, Yating, et al.
Publicado: (2023)

Association between blood eosinophil count and bacterial infection and clinical outcomes in patients with severe exacerbations of chronic obstructive pulmonary disease
por: Wang, Fei, et al.
Publicado: (2022)

Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease
por: Singh, Dave, et al.
Publicado: (2020)

Richness of sputum microbiome in acute exacerbations of eosinophilic chronic obstructive pulmonary disease
por: Qi, Yu-Jing, et al.
Publicado: (2020)

Efficacy of mRNA and Inactivated Whole Virus Vaccines Against COVID-19 in Patients with Chronic Respiratory Diseases
por: Kwok, Wang Chun, et al.
Publicado: (2023)

Association of Upon-Diagnosis Blood Eosinophilic Count with Frequency and Severity of Annual Exacerbation in Chronic Obstructive Pulmonary Disease: A Prospective Longitudinal Analysis
por: Kiani, Arda, et al.
Publicado: (2023)

Asthma, from mild to severe, is an independent prognostic factor for mild to severe Coronavirus disease 2019 (COVID‐19)
por: Kwok, Wang Chun, et al.
Publicado: (2022)

First reported case of afatinib‐associated toxic megacolon
por: Kwok, Wang Chun, et al.
Publicado: (2018)

Risk of Stroke and Post-Stroke Adverse Events in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease
por: Lin, Chao-Shun, et al.
Publicado: (2017)

Real-World Study on Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Unvaccinated Patients with Chronic Respiratory Diseases with Confirmed SARS-CoV-2 Infection Managed in Out-Patient Setting
por: Kwok, Wang Chun, et al.
Publicado: (2023)

Blood Count of Eosinophil Polymorphonuclear Leucocytes and Bronchial Hyperreactivity in Chronic Obstructive Pulmonary Disease
por: Cukic, Vesna
Publicado: (2017)

Factors Influencing the Stability of Blood Eosinophils Counts in Chronic Obstructive Pulmonary Disease Patients
por: Cai, Cheng-Sen, et al.
Publicado: (2022)

Differences in hospital admissions for acute exacerbations of COPD during the COVID-19 pandemic stratified by stable-state blood eosinophil count
por: Aung, Hnin, et al.
Publicado: (2023)

Blood eosinophil count-guided corticosteroid therapy and as a prognostic biomarker of exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Liu, Tao, et al.
Publicado: (2021)

Neuroprotective Mechanism of Lycium barbarum Polysaccharides against Hippocampal-Dependent Spatial Memory Deficits in a Rat Model of Obstructive Sleep Apnea
por: Lam, Chun-Sing, et al.
Publicado: (2015)

Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysis
por: Gan, Wen Qi, et al.
Publicado: (2005)

First successful case of chemical pleurodesis with oxytetracycline through Rocket® Pleural Vent™: ambulatory pneumothorax device for pneumothorax
por: Kwok, Wang Chun, et al.
Publicado: (2019)

Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state
por: Yang, Chia-Yu, et al.
Publicado: (2021)

Peripheral Blood Eosinophil as a Biomarker in Outcomes of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Wu, Hong-Xia, et al.
Publicado: (2019)

Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid Effects
por: Singh, Dave
Publicado: (2020)

The Combination of Hemogram Indexes to Predict Exacerbation in Stable Chronic Obstructive Pulmonary Disease
por: Liu, Xuanqi, et al.
Publicado: (2020)

Acute exacerbations of chronic obstructive pulmonary disease: treatment and prevention
por: Seemungal, Terence, et al.
Publicado: (2008)

Worsening of asthma control after recovery from mild to moderate COVID-19 in patients from Hong Kong
por: Kwok, Wang Chun, et al.
Publicado: (2023)

The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
por: Choi, Juwhan, et al.
Publicado: (2019)

Using Blood Eosinophil Count as a Biomarker to Guide Corticosteroid Treatment for Chronic Obstructive Pulmonary Disease
por: Sivapalan, Pradeesh, et al.
Publicado: (2021)

Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy
por: Benson, Victoria S, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eocjdevcm8880econmkc623rbv